PubMed

Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.

Parodi MB, Da Pozzo S, Ravalico G.

Br J Ophthalmol. 2003 Feb;87(2):177-83.PMID: 12543747 [PubMed - indexed for MEDLINE]Related articlesFree article

Sequence of early vascular events after photodynamic therapy.

Michels S, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2003 May;44(5):2147-54.PMID: 12714655 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.

Schmidt-Erfurth UM, Michels S.

Ophthalmology. 2003 Jul;110(7):1306-14.PMID: 12867383 [PubMed - indexed for MEDLINE]Related articles

Time course and morphology of vascular effects associated with photodynamic therapy.

Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S.

Ophthalmology. 2005 Dec;112(12):2061-9.PMID: 16325705 [PubMed - indexed for MEDLINE]Related articles

Early angiographic changes after laser treatment of choroidal neovascularisation in age-related macular degeneration.

Battaglia Parodi M, Da Pozzo S, Ravalico G.

Graefes Arch Clin Exp Ophthalmol. 2001 Dec;239(12):900-8.PMID: 11820694 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2002 Nov;120(11):1443-54.PMID: 12427056 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration.

Haddad WM, Coscas G, Soubrane G.

Br J Ophthalmol. 2002 Jun;86(6):663-9.PMID: 12034690 [PubMed - indexed for MEDLINE]Related articlesFree article

Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area.

Dewi NA, Yuzawa M, Tochigi K, Kawamura A, Mori R.

Jpn J Ophthalmol. 2008 Jul-Aug;52(4):277-81. Epub 2008 Sep 5.PMID: 18773265 [PubMed - indexed for MEDLINE]Related articles

Spotlight on verteporfin in subfoveal choroidal neovascularisation.

Keam SJ, Scott LJ, Curran MP.

Drugs Aging. 2004;21(3):203-9. Review.PMID: 14979737 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.

Montero JA, Ruiz-Moreno JM.

Br J Ophthalmol. 2003 Feb;87(2):173-6.PMID: 12543746 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of treatment parameters on selectivity of verteporfin therapy.

Michels S, Hansmann F, Geitzenauer W, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2006 Jan;47(1):371-6.PMID: 16384987 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration.

Eter N, Vogel A, Inhetvin-Hutter C, Spitznas M.

Eur J Ophthalmol. 2003 Oct;13(8):687-92.PMID: 14620172 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.

Arch Ophthalmol. 1999 Sep;117(9):1161-73. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496388 [PubMed - indexed for MEDLINE]Related articles

Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.

Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA.

Retina. 2007 Sep;27(7):825-31.PMID: 17891004 [PubMed - indexed for MEDLINE]Related articles

Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.

Keam SJ, Scott LJ, Curran MP.

Drugs. 2003;63(22):2521-54. Review.PMID: 14609361 [PubMed - indexed for MEDLINE]Related articles

One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.

Ophthalmology. 2008 Jan;115(1):141-6. Epub 2007 Jun 20.PMID: 17582498 [PubMed - indexed for MEDLINE]Related articles

Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration.

Obata R, Yanagi Y, Kami J, Takahashi H, Inoue Y, Tamaki Y.

Jpn J Ophthalmol. 2006 Jul-Aug;50(4):354-60.PMID: 16897221 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.

Verteporfin Roundtable 2000 and 2001 Participants; Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators.

Retina. 2002 Feb;22(1):6-18. Review.PMID: 11884872 [PubMed - indexed for MEDLINE]Related articles